India International Times Latest Business News from India
President Droupadi Murmu will virtually launch the TB Mukt Bharat Abhiyaan on Friday to reinvigorate the mission of TB elimination from the country by 2025.
Following the government’s initiative to end Tuberculosis or TB in the country five years ahead of Sustainable Development Goals (SDG) target of 2030 by the United Nations, the Abhiyaan will be launched in presence of Mansukh Mandaviya, Union Minister of Health and Family Welfare and other officials.
The virtual event will be attended by representatives from State and district health administration, corporates, industries, civil society and NGOs as the country reiterates the commitment towards TB elimination by 2025.
The TB Mukt Bharat Abhiyaan has been envisioned to bring together all community stakeholders to support those on TB treatment and accelerate the country’s progress towards TB elimination.
The President will also launch the Ni-kshay Mitra initiative which forms a vital component of the Abhiyaan. The Ni-kshay Mitra portal provides a platform for donors to provide various forms of support to those undergoing TB treatment. The three pronged support includes nutritional, additional diagnostic, and vocational support.
The launch event aims to highlight the need for a societal approach that brings together people from all backgrounds to achieve the ambitious target of eliminating TB from the country by 2025, ahead of the SDG targets set by the UN.
SDG target to eliminate TB
Tuberculosis is an infectious bacterial disease caused by Mycobacterium tuberculosis, which most commonly affects the lungs. In June 2022, WHO’s Director-General Dr Tedros Adhanom Ghebreyesus held a dialogue with WHO’s Civil Society Task Force on Tuberculosis (CSTF-TB) sought to support the rapid adoption of WHO guidelines at country level.
It has called upon nations to increase access to the best evidence-based interventions for people and communities affected by TB, including prevention, detection and treatment of people with TB and related comorbidities, with the involvement of civil society and affected communities.
